Lyudmila Ju. Tregubova

Lyudmila Ju. Tregubova

Auto-generated profile, based on publicly available information

Lyudmila Ju. Tregubova

Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Hygiene and sanitation
Verified
Journal Article
Closed access
PDF file
OSOlga N. Savostikova
Olga N. Savostikova
ОУОльга Владимировна Ушакова
Ольга Владимировна Ушакова
LTLyudmil Ju. Tregubova
Lyudmil Ju. Tregubova
The work is devoted to the study of the formation of bottom sediments and silt, their impact on the state of aquatic ecosystems, effective research methods and their practical application. Due to the continuous anthropogenic load, heavy metals, polycyclic aromatic hydrocarbons and other pollutants constantly accumulate in the silt and bottom formations. They undergo various chemical processes that can produce compounds that are even more toxic. The accumulation of this complex of pollutants subsequently becomes a source of secondary pollution, affecting the quality of water in reservoirs, reducing the species diversity of aquatic organisms and, through migration and movement along food chains, negatively affecting the condition of plants, animals and people, ultimately violating the processes of self-purification. Silt and bottom sediments thus become indicators of water pollution. On secondary deposits, biological processes are inhibited, anaerobic conditions arise, acidity increases, which contributes to the constant release and entry of harmful gases into the atmosphere. One of the main consequences of this process is the greenhouse effect and the violation of the heat balance. One of the ways to monitor bottom sediments is bio testing. In this method, crustaceans are chosen as test organisms because of their sensitivity to pollution, wide distribution. Bio testing can be used as an independent method for assessing the state of aquatic ecosystems, and in their integral assessment. Now in Russia there is no system for assessing the quality of bottom sediments, which greatly complicates the assessment of the state of surface water bodies and the prediction of negative processes. Thus, data on the composition of pollutants in silt and bottom sediments are not applicable for ecological characterization. Therefore, it seems necessary to create a unified methodology and establish interdepartmental communication of specialists in order to fully assess the pollution of water bodies and respond in time to threatening levels.

23 October 2022 in Hygiene and sanitation
Verified
Journal Article
Closed access
PDF file
MVMaria A. Vodianova
Maria A. Vodianova
OUOlga V. Ushakova
Olga V. Ushakova
NRNikolay V. Rusakov
Nikolay V. Rusakov
IEIrina S. Evseeva
Irina S. Evseeva
LTLudmila Yu. Tregubova
Ludmila Yu. Tregubova
МВМария Александровна Водянова
Мария Александровна Водянова
Introduction. So far, the main regulatory document on the justification of hygiene standards for chemical pollution of the soil has not been revised. In accordance with the provisions of the state policy of the Russian Federation in the field of ensuring chemical and biological safety for the period up to 2025 and beyond 1, it is advisable to develop new approaches to assess the hazard of chemicals that pollute the soil, taking into account international standards and risk assessment for public health. The purpose of the study is to develop methodological approaches and recommendations in substantiating the hygienic standards of chemical pollution of the soil, taking into account modern legal requirements in the field of technical regulation and international standards. Materials and methods. Information and analytical methods for database FIPS (Federal Institute of Industrial Property), as well as data from scientific publications and our own research analytical data were used in the study. Results. According to our study, it was revealed that there is no software for assessment of the environment impact of chemicals on the soil, with the exception of assessment in emergency situations. In this regard, based on research, we have proposed a software layout to automatically assess the risk of exposure to chemicals through the soil, and to carry out mathematical modelling and build a predictive model for the impact of chemicals on soil and public health as part of their hygiene regulation. Limitations. The study was limited to the study of patents for software systems for computers that are designed to assess the impact of the activities of enterprises in the FGBU “FIPS” system, placed in open sources and aimed at solving problems related to ensuring the safety of citizens, calculating risk, taking into account relevant information on the actual state environmental objects. The data obtained in the work are of undoubted interest, including when working out the software layout. Conclusion. A methodology for a comprehensive risk assessment of the impact of chemicals on human health through the soil factor is proposed, which will be included in the draft guidelines for substantiating the hygienic standards of chemicals in the soil, taking into account the use of software for the automatic calculation of estimated indicators to substantiate the maximum permissible concentration (MPC) of chemicals in the soil of populated areas in depending on various factors, including types of land use.

31 May 2022 in Hygiene and sanitation
Verified
Journal Article
Closed access
PDF file
АААнна Венедиктовна Алексеева
Анна Венедиктовна Алексеева
IEIrina S. Evseeva
Irina S. Evseeva
OUOlga V. Ushakova
Olga V. Ushakova
LTLyudmila Ju. Tregubova
Lyudmila Ju. Tregubova
The article contains a review of the literature devoted to research the possibility of using polymeric materials as returnable containers for the supply of water to consumers. When conducting a literature search, the following databases were used: Pubmed, Scopus, Web of Science, MedLine, Global Health, RSCI. The purpose of the work was to collect information on the sources of contamination of drinking water packed in polymer containers based on the literature data and evaluate the possibilities of its safe reuse. Conducted information and analytical studies have shown that the repeated use of polymer containers (in particular, PET containers) may be unreliable, both in terms of chemical and microbiological safety. The paper identifies the main chemical components migrating from polymer containers, which have the greatest impact on the quality of drinking water. The influence of storage temperature, the duration of contact of plastic with water, abrasion of the material, the influence of photochemical aging of bottles and the impact of disinfectants are also considered. The conducted studies have shown that at the moment there are no regulatory and methodological documents regulating the possibility and conditions for the reuse of plastic containers (19-liter bottles), the number of cycles of its reuse, the indicators by which the assessment is made, and the criteria by which the already used container cannot be used further. The possibility of multiple reuse of polymer containers for water storage currently needs to be regulated. There is little literature data on the wear resistance of various types of plastic and the maximum number of cycles of detergents and disinfectants that it can withstand without destroying its structure. Taking into account the data on the destructive changes in polymers under the influence of external factors (temperature, sunlight, etc.), and in the process of treating it with detergents, it is necessary to propose and scientifically substantiate documents regulating the use of returnable packaging, taking into account the materials of modern research. It is also necessary to search for safe, simple and effective methods and means of disinfection of polymer containers.

17 March 2026 in Medical Technologies. Assessment and Choice
Verified
Journal Article
Closed access
ASA.A. Slabikova
A.A. Slabikova
LGL.YU. Gorbachenko
L.YU. Gorbachenko
VDV.S. Dombrovskiy
V.S. Dombrovskiy
KMK.I. Matrenin
K.I. Matrenin
SASergey Avdeev
Sergey Avdeev
Objective. To evaluate clinical and economic impact of cost reimbursement for treatment with dual and triple fixed-dose therapeutic combinations in adults with moderate, severe, and very severe chronic obstructive pulmonary disease (COPD). Material and methods. A decision-analytic model was developed to evaluate clinical and economic outcomes associated with two alternative strategies of pharmacological coverage in COPD. The model estimated changes in the number of moderate and severe exacerbations and COPD-related mortality (including working-age population) following broader implementation of reimbursed maintenance therapy. Economic evaluation included: (1) direct medical costs—pharmacotherapy expenditures, costs of outpatient and inpatient management, emergency medical services; (2) indirect costs — GDP losses caused by premature mortality and productivity losses caused by exacerbation-related withdrawal from the workforce. Results. Expanding pharmacotherapy coverage had led to reductions in moderate exacerbations by 14% and severe exacerbations by 13%. Lower incidence of exacerbation led to reductions in outpatient visits, emergency medical services, admissions and associated direct medical costs. Over the year, the number of deaths among patients decreased by 6% that translated into estimated reduction in GDP losses by approximately 10.6 billion over a 10-year period when examining of working-age cohort. Conclusion. Expansion of reimbursed maintenance pharmacotherapy in outpatient setting, despite higher upfront medication expenditures, could be associated with fewer COPD exacerbations, reduced healthcare resource utilization, and substantial reductions in direct medical and indirect societal costs.

19 August 2026 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
LGL. Yu. Gorbachenko
L. Yu. Gorbachenko
KMK. I. Matrenin
K. I. Matrenin
ASA. A. Slabikova
A. A. Slabikova
RTR. A. Teryan
R. A. Teryan
DPD. N. Pustovalov
D. N. Pustovalov
VOV. V. Omelyanovskiy
V. V. Omelyanovskiy
Objective : To estimate the direct medical costs associated with the treatment of adult patients with obesity in the Russian Federation, including the costs of pharmacotherapy for obesity, management of comorbidities and hospitalizations due to specific obesity-related complication. Material and methods. A mathematical model was developed to analyze the direct medical costs of pharmacotherapy for obesity and related comorbidities over a 1-year time horizon. The analysis included adults aged 18–69 years with obesity (body mass index (BMI) ≥30 kg/m²); a subgroup of individuals with BMI ≥35 kg/m² was analyzed separately. The target population size was determined using national epidemiological data, stratified by sex, age, and obesity class. The model evaluated the costs of pharmacotherapy for obesity, management of comorbid conditions, and hospitalizations associated with type 2 diabetes mellitus, coronary heart disease, and arterial hypertension. Treatment costs were calculated based on dosing regimens, the State Register of Maximum Selling Prices, and public procurement data; hospitalization costs were estimated using diagnosis-related groups. Results . The estimated number of adults with obesity was 21.64 million, including 5.45 million individuals with BMI ≥35 kg/m². In the modeled scenario of universal drug coverage, annual pharmacotherapy costs were estimated at 3.1 trillion rubles for the overall population and 778 billion rubles for the subgroup with BMI ≥35 kg/m². The estimated number of comorbidity cases was 4.44 million for coronary heart disease, 15.2 million for arterial hypertension, and 7.03 million for type 2 diabetes mellitus. Pharmacotherapy costs for these conditions amounted to 69, 324, and 396 billion rubles, respectively. Annual hospitalization costs were estimated at 377 billion rubles for type 2 diabetes mellitus and 89 billion rubles for coronary heart disease. Conclusion . The management of adults with obesity and comorbid conditions within the Russian healthcare system is associated with substantial direct medical costs. Reducing this burden requires a combination of prevention, early detection, and long-term patient management.